Pinnacle Wealth Planning Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$295K Sell
1,275
-362
-22% -$89.4K 0.03% 359
2026
Q2
$394K Buy
1,637
+20
+1% +$4.38K 0.04% 276
2026
Q1
$306K Sell
1,617
-64
-4% -$11.2K 0.03% 331
2025
Q4
$286K Hold
1,681
– – 0.03% 344
2025
Q3
$222K Buy
+1,681
New +$202K 0.03% 415
2021
Q1
– Sell
-25
Closed -$4K – 1154
2020
Q4
$4K Buy
+25
New +$3.72K ﹤0.01% 1731

Other funds holding JAZZ

Pinnacle Wealth Planning Services's JAZZ Position: Q3 2026 in Review

Pinnacle Wealth Planning Services reduced its Jazz Pharmaceuticals (JAZZ) stake by 22% in Q3 2026, selling an estimated $89.4K and leaving 1,275 shares worth $295K. The position accounts for 0.03% of the portfolio, ranked #359.

Pinnacle Wealth Planning Services first reported a position in JAZZ in Q4 2020 and has held it in 6 quarters since. The position peaked at $394K in Q2 2026. 671 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Pinnacle Wealth Planning Services held 1,275 shares of Jazz Pharmaceuticals worth $295K as of Q3 2026.
  • Pinnacle Wealth Planning Services sold 362 Jazz Pharmaceuticals shares in Q3 2026, an estimated $89.4K.
  • Jazz Pharmaceuticals made up 0.03% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #359 holding.
  • Pinnacle Wealth Planning Services first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 6 quarters since.
  • Pinnacle Wealth Planning Services's Jazz Pharmaceuticals position peaked at $394K in Q2 2026.
  • 671 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.